Press Releases
-
Apr16
Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance
RUTHERFORD, N.J., April 16, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling
-
Apr2
Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic Business Updates
Conference call at 4:30 p.m. EDT, Monday, April 2, 2018 RUTHERFORD, N.J., April 02, 2018 (GLOBE NEWSWIRE) -- Cancer
-
Mar26
Cancer Genetics to Host Fourth Quarter and Full Year 2017 Financial Results
Conference call at 4:30 p.m. EDT, Monday, April 2, 2018 RUTHERFORD, N.J., March 26, 2018 (GLOBE NEWSWIRE) -- Cancer
-
Feb5
Cancer Genetics, Inc. Chief Executive Officer Steps Down
• Board Appoints COO, Jay Roberts, Interim Chief Executive Officer RUTHERFORD, N.J., Feb. 05, 2018 (GLOBE
-
Jan17
Cancer Genetics Expands Its Industry-Leading Immuno-Oncology Panel, Complete::IO™, to be the Most Comprehensive for Immune Profiling & Monitoring
- Simultaneously Assesses 27 Unique Immune Markers - Determines Optimal IO Therapies and Tracks Response and
-
Dec28
Cancer Genetics Receives Non-Dilutive Funding of $1.1 Million through New Jersey Technology Business Tax Certificate Transfer (NOL) Program
RUTHERFORD, N.J., Dec. 28, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling
-
Dec19
Cancer Genetics Receives New York State Approval for FDA-Approved Oncomine Dx Target Test by Thermo Fisher Scientific
The test serves as a companion diagnostic for three targeted therapies in non-small cell lung cancer (NSCLC) Global
-
Dec11
Cancer Genetics advances understanding of immune response and measurement in lymphomas by combining PD-L1 expression analysis with RNA analysis
Study Presented at the 59th American Society of Hematology (ASH) Annual MeetingStudy focused on DLBCL (Diffuse Large
-
Dec8
Cancer Genetics Prices $7 Million Registered Direct Offering
RUTHERFORD, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a leader in enabling
-
Nov30
Cancer Genetics to Participate in Upcoming Investor Conferences
LD Micro Main Event and Benchmark Micro Cap Conference RUTHERFORD, N.J., Nov. 30, 2017 (GLOBE NEWSWIRE) -- Cancer
